STK26 and triple-A syndrome: Compared with AMEXO, HMEXO enriched with miR-19b-3p more effectively attenuated AAA formation and inhibited mitochondrial fission and ROS generation in senescent VSMCs by regulating the MST4/ERK/Drp1 pathway.